DEA License Renewal Training

The new Medication Access and Training Expansion (MATE) Act requires most licensed prescribers who are either renewing or applying for a new controlled substance DEA license to have completed at least 8 hours of opioid or other substance use disorders (SUD) training. The MATE act went into effect on June 27, 2023. 

Opioid/SUD Training Resources: 

• Munson Healthcare On-Demand CME
  • Best Practices and Tools for Chronic Pain (1-hour recorded webinar)
  • Chronic Pain Management in Primary Care (1-hour recorded webinar)
  • Addressing the "5th vital sign": Pain Management Beyond Opioids (1-hour recorded webinar)
  • Pain Management Pearls in the Inpatient Setting (1-hour recorded webinar)
• UpToDate Links to meet MATE Act Requirements
• Michigan Opioid Collaborative
• Yale Program in Addiction Medicine
• SUD and Addiction Education | AMA
• MSMS New DEA Requirement Education

Additionally, prescriptions for buprenorphine now only require a standard DEA registration number. The x-waiver is no longer required for any prescriber to treat patients with buprenorphine for opioid use disorder. Learn more about this change.